Universal Health Services, Inc. UHS
Healthcare · Medical Care Facilities · United States · S&P 500
Based on the available data, Universal Health Services, Inc. gets an algorithmic score of 56/100. It trades at 175.73 $, with a bearish technical trend (RSI 51.6) and 32.2% annual volatility.
Updated: 2026-09-30
Open in the interactive tool →
Strengths
- High ROE (20.9%): generates strong profit on equity.
- Attractive free-cash-flow yield (8.0%).
- Low valuation (P/E 7.3).
- Low beta (0.55): defensive profile.
- Meaningful dividend (46.00%).
Weaknesses
- —
Fundamentals
| P/E | 7.17 |
| Forward P/E | 7.32 |
| PEG | 1.21 |
| P/B | 1.38 |
| EV/EBITDA | 5.79 |
| P/S | 0.57 |
| ROE % | 20.95 |
| ROA % | 8.32 |
| Gross margin % | 44.61 |
| Operating margin % | 11.14 |
| Net margin % | 8.42 |
| Revenue growth % (y/y) | 8.30 |
| Earnings growth % (y/y) | 10.10 |
| Revenue CAGR % | 9.03 |
| Earnings CAGR % | 30.13 |
| Debt/Equity % | 68.74 |
| Current ratio | 1.12 |
| FCF yield % | 7.96 |
| Dividend yield % | 46.00 |
| Payout % | 3.27 |
Returns
| 1 month | +2.5 % |
| 3 months | +18.3 % |
| 6 months | -3.2 % |
| YTD | -19.8 % |
| 1 year | -12.1 % |
| 3 years | +40.2 % |
| 5 years | +24.1 % |
Risk
| 1-year volatility | 32.2 % |
| Beta | 0.55 |
| 5-year max drawdown | -43.3 % |
| Sharpe 1A | -0.36 |
Macroeconomic context
Defensive with structural growth (ageing population). Risks: drug-pricing regulation, patents and clinical trials. Low correlation with the cycle. As a US company, its valuation depends on the Fed, 10-year Treasury yields and the US earnings cycle.
How the score is calculated
The score combines profitability (ROE, ROA, net margin), growth (revenue and earnings), valuation (P/E, EV/EBITDA, free cash flow), financial strength (debt and liquidity; not applied to banks and insurers) and momentum (6 and 12-month returns and trend). It is an educational quantitative filter, not a buy or sell recommendation.